ArticleModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2023

HER2 Genetic Intratumor Heterogeneity Is Associated With Resistance to Trastuzumab and Trastuzumab Emtansine Therapy in Recurrent High-Grade Endometrial Cancer.

Sherry Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.